Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

1.51
Delayed Data
As of Jun 23
 -0.16 / -9.58%
Today’s Change
1.50
Today|||52-Week Range
3.53
-40.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues12.5K32.5K12.0K12.5K
 
 
 
 
 
Depreciation And Amortization227.1K235.3K240.1K238.3K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses14.0M8.7M11.0M11.5M
 
 
 
 
 
Research And Development6.8M6.0M8.2M8.0M
 
 
 
 
 
Total Operating Expenses14.2M9.0M11.3M11.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.2M-8.9M-11.3M-11.7M
 
 
 
 
 
Other Expenses-860.00262.00-25.0K3.2K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.0M-8.7M-11.1M-11.5M
 
 
 
 
 
Net Income-14.0M-8.7M-11.1M-11.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.2M42.3M42.3M42.4M
 
 
 
 
 
Shares To Calculate EPS Diluted42.2M42.3M42.3M42.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.33-$0.21-$0.26-$0.27
 
 
 
 
 
EPS Diluted-$0.33-$0.21-$0.26-$0.27